Just a question, Stuart: are you an investor in Longevinex?
From: Stuart Cracraft <cracraft@...>
To: ForumPoint <forumpoint@googlegroups.com>; resveratrol-users@yahoogroups.com; longevinex-users@yahoogroups.com
Cc: Steve Omohundro <steveomohundro@...>
Sent: Thursday, July 9, 2009 11:20:31 PM
Subject: [resveratrol-users] [Fwd: Scientific black out of resveratrol science]
Nicholas Wade is one of the major science writers
at the New York Times.
Bill, here, is trying to knock some sense into
the media and Wade. (Wade is a smart guy, did early
interviews of Sinclair who discovered the effects,
etc.)
Well, back to another glass of red wine here....
The French are right!
--Stuart
-------- Original Message --------
| Subject: | Scientific black out of resveratrol science |
|---|---|
| Date: | Thu, 09 Jul 2009 23:02:55 -0400 (EDT) |
| From: | BSardi@... |
| To: | nwade@... |
Nicholas Wade July 10, 2009
NYTIMES
From: Bill Sardi, Resveratrol Partners LLC,
dba LONGEVINEX®
The headlines of the past day involving
calorie restricted monkeys and rapamycin in pursuit of strategies to
prolong the human healthspan are remarkable.
Yet I am perplexed by statements that hail
rapamycin, an immune suppressing drug, which say a relatively short
course of rapamycin is able to prolong life in laboratory mice at a
late-stage of life, something that calorie restriction takes a lifetime
to achieve.
However, when the very same
university-based researchers who performed the primate studies reported
in late 2008 that our proprietary matrix of small molecules
(resveratrol, quercetin, IP6 rice bran) produced a profound genomic
effect, far greater than calorie restriction or plain resveratrol, and
produced changes at an earlier stage of life that are only seen with
life-long calorie restriction, not a word was said about this by the
news press.
In fact, there has been a complete
black-out by the research community and the news press regarding this
discovery. Since its publication in Experimental Gerontology in Sept
of 2008, not one other published paper has referred to the Longevinex
study. The black-balling has been total and complete. One wonders why?
It is clear that the world need not consume
1000 bottles of wine a day to achieve longevity nor does the world need
to wait another ten years for confirmation. In fact, aging populations
simply don't have another decade to wait. The International Monetary
Fund said today that the burden of caring for chronically ill retirees
is 10-times greater than the current economic crisis.
The French have far more centenarians per
capita than any other developed nation, with the greatest longevity and
health exhibited among those who consume just 3-5 glasses of red
wine, providing just 180-300 mg of polyphenols. Remove the alcohol and
you have an anti-aging pill. That is what Longevinex® has
attempted to produce. That is what Professor Roger Corder, author of The
Red Wine Diet, attests.
The majority of the science shows there is
a synergistic effect exhibited with the provision of a variety of small
molecules at relatively doses, as provided in Longevinex®. The public is at risk for following irresponsible advice
to consume thousands of milligrams of resveratrol, with side
effects (anemia, headaches, Achilles heel soreness) now being reported
among mega-dose resveratrol pill users.